RVTYRevvity

Health care · Lab Instruments · NYSE

We are a leading provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. 10-K, Item 1

Employees: 11,000
Headquarters: Waltham, MA
CEO: Prahlad R. Singh
Next results: around Jan 12, 2027

Compare with peers → Embed

RVTY and 9 peers, year by year

The 9 Health care companies closest to RVTY in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

5 years 10 years Download CSV

Choose the peers

Each company's latest fiscal year
Company	Year	Revenue	Sales growth	Gross margin	Operating margin	Net margin	FCF margin	Return on equity	Debt / equity
RVTY Revvity	FY2025	$2.9B	+3.7%	-	12.5%	8.4%	17.8%	3.3%	0.44
PODD Insulet Corporation	FY2025	$2.7B	+30.7%	71.6%	17.5%	9.1%	13.9%	16.3%	0.63
MRNA Moderna	FY2025	$1.9B	−39.9%	-	−158.1%	−145.2%	−106.2%	−32.6%	0.07
WST West Pharmaceutical Services	FY2025	$3.1B	+6.3%	35.9%	19.0%	16.1%	15.3%	15.5%	0.06
VEEV Veeva Systems	FY2026	$3.2B	+16.3%	75.5%	28.7%	28.4%	-	12.6%	-
CRL Charles River Laboratories	FY2025	$4.0B	−0.9%	-	0.6%	−3.6%	12.9%	−4.6%	0.68
ALGN Align Technology	FY2025	$4.0B	+0.9%	67.2%	13.5%	10.2%	12.2%	10.1%	-
MTD Mettler Toledo	FY2025	$4.0B	+4.0%	59.4%	-	21.6%	21.1%	n/m	n/m
COO Cooper Companies	FY2025	$4.1B	+5.1%	65.5%	16.7%	9.2%	10.6%	4.6%	0.30
ILMN Illumina, Inc.	FY2025	$4.3B	−0.7%	66.1%	18.6%	19.6%	21.4%	31.2%	0.73

Revenuepeer median $4.0B

Sales growthpeer median +4.0%

Gross marginpeer median 66.1%

Operating marginpeer median 17.1%

Net marginpeer median 10.2%

FCF marginpeer median 13.4%

Return on equitypeer median 11.4%

Debt / equitypeer median 0.47

ILMN 0.73
CRL 0.68
PODD 0.63
RVTY 0.44
COO 0.30
MRNA 0.07
WST 0.06
VEEV -
ALGN -
MTD n/m

RevenueSales growthGross marginOperating marginNet marginFree cash flowFCF marginReturn on equityDebt / equityEPS (diluted)

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
RVTY Dec	$2.1B	$2.3B	$2.8B	$2.9B	$3.8B	$3.8B	$3.3B	$2.8B	$2.8B	$2.9B
PODD Dec	$367.0M	$463.8M	$563.8M	$738.2M	$904.4M	$1.1B	$1.3B	$1.7B	$2.1B	$2.7B
MRNA Dec	$108.4M	$205.8M	$135.1M	$60.2M	$803.0M	$18.5B	$19.3B	$6.8B	$3.2B	$1.9B
WST Dec	$1.5B	$1.6B	$1.7B	$1.8B	$2.1B	$2.8B	$2.9B	$2.9B	$2.9B	$3.1B
VEEV Jan	$409.2M	$550.5M	$690.6M	$862.2M	$1.1B	$1.9B	-	$2.2B	$2.4B	$2.7B
CRL Dec	$1.7B	$1.9B	$2.3B	$2.6B	$2.9B	$3.5B	$4.0B	$4.1B	$4.0B	$4.0B
ALGN Dec	$1.1B	$1.5B	$2.0B	$2.4B	$2.5B	$4.0B	$3.7B	$3.9B	$4.0B	$4.0B
MTD Dec	$2.5B	$2.7B	$2.9B	$3.0B	$3.1B	$3.7B	$3.9B	$3.8B	$3.9B	$4.0B
COO Oct	$2.0B	$2.1B	$2.5B	$2.7B	$2.4B	$2.9B	$3.3B	$3.6B	$3.9B	$4.1B
ILMN Dec	$2.4B	$2.8B	$3.3B	$3.5B	$3.2B	$4.5B	$4.6B	$4.5B	$4.4B	$4.3B
Peer median	$1.5B	$1.6B	$2.0B	$2.4B	$2.4B	$3.5B	$3.8B	$3.8B	$3.9B	$4.0B

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
RVTY Dec	+0.5%	+6.7%	+23.1%	+3.8%	+31.2%	+43.7%	−13.5%	−16.9%	+0.2%	+3.7%
PODD Dec	+39.1%	+26.4%	+21.6%	+30.9%	+22.5%	+15.1%	+18.8%	+30.0%	+22.1%	+30.7%
MRNA Dec	-	+89.9%	−34.4%	−55.4%	n/m	n/m	+4.3%	−64.4%	−52.7%	−39.9%
WST Dec	+7.8%	+6.0%	+7.4%	+7.1%	+16.7%	+31.9%	+2.0%	+2.2%	−1.9%	+6.3%
VEEV Jan	-	+32.9%	+25.4%	+24.9%	+28.1%	+26.3%	-	+16.4%	+9.7%	+16.2%
CRL Dec	+23.3%	+10.5%	+22.0%	+15.7%	+11.5%	+21.1%	+12.3%	+3.9%	−1.9%	−0.9%
ALGN Dec	+27.7%	+36.4%	+33.5%	+22.4%	+2.7%	+59.9%	−5.5%	+3.4%	+3.5%	+0.9%
MTD Dec	+4.7%	+8.6%	+7.7%	+2.5%	+2.5%	+20.5%	+5.4%	−3.4%	+2.2%	+4.0%
COO Oct	+9.4%	+8.8%	+18.4%	+4.8%	−8.4%	+20.2%	+13.2%	+8.6%	+8.4%	+5.1%
ILMN Dec	+8.0%	+14.8%	+21.1%	+6.3%	−8.6%	+39.7%	+1.3%	−1.7%	−2.9%	−0.7%
Peer median	+9.4%	+14.8%	+21.1%	+7.1%	+7.1%	+23.7%	+4.9%	+3.4%	+2.2%	+4.0%

Gross margin, FY2016 to FY2025

Gross profit / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
RVTY Dec	47.9%	47.6%	48.3%	48.4%	55.8%	63.6%	60.1%	-	-	-
PODD Dec	57.5%	59.8%	65.7%	65.1%	64.4%	68.4%	61.7%	68.3%	69.8%	71.6%
MRNA Dec	-	-	-	-	-	-	-	-	-	-
WST Dec	33.2%	32.1%	31.8%	32.9%	35.8%	41.5%	39.4%	38.3%	34.5%	35.9%
VEEV Jan	65.2%	68.5%	69.4%	71.6%	72.5%	72.8%	-	71.7%	71.3%	74.5%
CRL Dec	-	-	-	-	-	-	-	-	-	-
ALGN Dec	75.5%	75.8%	73.6%	72.5%	71.3%	74.3%	70.5%	70.1%	70.0%	67.2%
MTD Dec	57.3%	57.8%	57.4%	57.9%	58.4%	58.4%	58.9%	59.2%	60.1%	59.4%
COO Oct	59.6%	63.9%	64.4%	66.2%	63.1%	66.9%	64.7%	65.6%	66.6%	65.5%
ILMN Dec	69.5%	66.4%	69.0%	69.6%	68.0%	69.7%	64.8%	60.9%	65.4%	66.1%
Peer median	59.6%	63.9%	65.7%	66.2%	64.4%	68.4%	63.2%	65.6%	66.6%	66.1%

Operating margin, FY2016 to FY2025

Operating income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
RVTY Dec	13.9%	13.1%	11.7%	12.6%	22.9%	32.9%	22.4%	10.9%	12.6%	12.5%
PODD Dec	−2.9%	−1.6%	4.9%	6.8%	5.7%	11.5%	2.9%	13.0%	14.9%	17.5%
MRNA Dec	−206.4%	−130.9%	−306.0%	−906.8%	−95.0%	72.0%	48.9%	−61.9%	−121.9%	−158.1%
WST Dec	12.9%	14.1%	14.0%	16.1%	19.0%	26.6%	25.4%	22.9%	19.7%	19.0%
VEEV Jan	19.2%	21.9%	22.9%	25.8%	25.9%	27.3%	-	21.3%	18.2%	25.2%
CRL Dec	14.1%	15.5%	14.6%	13.4%	14.8%	16.7%	16.4%	14.9%	5.6%	0.6%
ALGN Dec	23.1%	24.0%	23.7%	22.5%	15.7%	24.7%	17.2%	16.7%	15.2%	13.5%
MTD Dec	-	-	-	-	-	-	-	-	-	-
COO Oct	16.5%	20.1%	15.9%	20.6%	12.8%	17.3%	15.3%	14.8%	18.1%	16.7%
ILMN Dec	24.5%	22.0%	26.5%	27.8%	17.9%	−2.7%	−91.2%	−23.7%	−19.1%	18.6%
Peer median	15.3%	17.8%	15.3%	18.4%	15.2%	21.0%	16.4%	14.9%	15.1%	17.1%

Net margin, FY2016 to FY2025

Net income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
RVTY Dec	11.1%	13.0%	8.6%	7.9%	19.2%	24.6%	17.2%	25.2%	9.8%	8.4%
PODD Dec	−7.9%	−5.8%	0.6%	1.6%	0.8%	1.5%	0.4%	12.2%	20.2%	9.1%
MRNA Dec	−199.5%	−124.3%	−284.8%	−853.7%	−93.0%	66.1%	43.4%	−68.8%	−110.0%	−145.2%
WST Dec	9.5%	9.4%	12.0%	13.1%	16.1%	23.4%	20.3%	20.1%	17.0%	16.1%
VEEV Jan	13.3%	14.1%	21.9%	26.7%	27.3%	23.1%	-	22.6%	22.2%	26.0%
CRL Dec	9.2%	6.6%	10.0%	9.6%	12.5%	11.0%	12.2%	11.5%	0.5%	−3.6%
ALGN Dec	17.6%	15.7%	20.4%	18.4%	71.8%	19.5%	9.7%	11.5%	10.5%	10.2%
MTD Dec	15.3%	13.8%	17.5%	18.6%	19.5%	20.7%	22.3%	20.8%	22.3%	21.6%
COO Oct	13.9%	17.4%	5.5%	17.6%	9.8%	100.8%	11.7%	8.2%	10.1%	9.2%
ILMN Dec	19.3%	26.4%	24.8%	28.3%	20.3%	16.8%	−96.1%	−25.8%	−28.0%	19.6%
Peer median	13.3%	13.8%	12.0%	17.6%	16.1%	20.7%	11.9%	11.5%	10.5%	10.2%

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
RVTY Dec	$318.9M	$249.4M	$217.8M	$287.1M	$828.5M	$1.3B	$594.2M	$9.9M	$541.7M	$509.4M
PODD Dec	−$6.2M	−$32.5M	−$121.5M	−$65.3M	−$45.0M	−$180.0M	−$3.9M	$70.1M	$305.3M	$377.7M
MRNA Dec	$33.6M	−$389.9M	−$436.6M	−$491.0M	$2.0B	$13.3B	$4.6B	−$3.8B	−$4.1B	−$2.1B
WST Dec	$49.2M	$132.5M	$183.9M	$240.8M	$298.1M	$330.6M	$439.4M	$414.5M	$276.4M	$468.9M
VEEV Jan	$59.0M	$137.1M	$223.8M	$302.4M	$434.3M	-	-	-	-	-
CRL Dec	$261.6M	$235.6M	$301.1M	$340.4M	$380.0M	$532.0M	$294.9M	$365.4M	$501.6M	$518.5M
ALGN Dec	$177.1M	$242.8M	$331.4M	$597.6M	$507.3M	$771.4M	$276.8M	$608.1M	$622.7M	$490.8M
MTD Dec	$336.8M	$388.9M	$422.3M	$506.1M	$632.2M	$801.2M	$737.8M	$860.6M	$864.4M	$848.6M
COO Oct	$357.0M	$466.4M	$475.3M	$421.1M	$176.2M	$524.2M	$450.4M	$215.0M	$288.1M	$433.7M
ILMN Dec	$519.0M	$565.0M	$846.0M	$842.0M	$891.0M	$337.0M	$106.0M	$283.0M	$709.0M	$931.0M
Peer median	$177.1M	$235.6M	$301.1M	$340.4M	$434.3M	$528.1M	$367.2M	$324.2M	$403.5M	$479.8M

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
RVTY Dec	15.1%	11.0%	7.8%	10.0%	21.9%	34.6%	17.9%	0.4%	19.7%	17.8%
PODD Dec	−1.7%	−7.0%	−21.6%	−8.8%	−5.0%	−16.4%	−0.3%	4.1%	14.7%	13.9%
MRNA Dec	31.0%	−189.4%	−323.3%	−815.5%	244.0%	72.2%	23.8%	−55.9%	−125.3%	−106.2%
WST Dec	3.3%	8.3%	10.7%	13.1%	13.9%	11.7%	15.2%	14.1%	9.6%	15.3%
VEEV Jan	14.4%	24.9%	32.4%	35.1%	39.3%	-	-	-	-	-
CRL Dec	15.6%	12.7%	13.3%	13.0%	13.0%	15.0%	7.4%	8.8%	12.4%	12.9%
ALGN Dec	16.4%	16.5%	16.9%	24.8%	20.5%	19.5%	7.4%	15.7%	15.6%	12.2%
MTD Dec	13.4%	14.3%	14.4%	16.8%	20.5%	21.6%	18.8%	22.7%	22.3%	21.1%
COO Oct	18.2%	21.8%	18.8%	15.9%	7.2%	17.9%	13.6%	6.0%	7.4%	10.6%
ILMN Dec	21.6%	20.5%	25.4%	23.8%	27.5%	7.4%	2.3%	6.3%	16.2%	21.4%
Peer median	15.6%	14.3%	14.4%	15.9%	20.5%	16.5%	10.5%	7.6%	13.6%	13.4%

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
RVTY Dec	10.9%	11.7%	9.2%	8.1%	19.5%	13.2%	7.7%	8.8%	3.5%	3.3%
PODD Dec	−45.8%	−16.9%	1.6%	15.3%	1.1%	3.0%	1.0%	28.2%	34.5%	16.3%
MRNA Dec	n/m	n/m	−25.1%	−43.7%	−29.2%	86.3%	43.7%	−34.0%	−32.7%	−32.6%
WST Dec	12.9%	11.8%	14.8%	15.4%	18.7%	28.3%	21.8%	20.6%	18.4%	15.5%
VEEV Jan	10.4%	11.4%	16.7%	18.6%	18.1%	14.7%	-	13.1%	11.3%	12.2%
CRL Dec	18.5%	11.8%	17.2%	15.4%	17.2%	15.4%	16.3%	13.2%	0.6%	−4.6%
ALGN Dec	19.0%	20.0%	31.9%	32.9%	54.9%	21.3%	10.0%	12.3%	10.9%	10.1%
MTD Dec	88.4%	68.7%	86.9%	133.3%	n/m	n/m	n/m	n/m	n/m	n/m
COO Oct	10.2%	11.7%	4.2%	12.9%	6.2%	42.4%	5.4%	3.9%	4.9%	4.6%
ILMN Dec	21.1%	26.4%	22.0%	21.7%	14.0%	7.1%	−66.7%	−20.2%	−51.5%	31.2%
Peer median	15.7%	11.8%	16.7%	15.4%	15.6%	18.4%	10.0%	12.7%	7.9%	11.2%

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
RVTY Dec	0.49	0.80	0.73	0.74	0.53	0.70	0.60	0.50	0.41	0.44
PODD Dec	5.27	3.57	2.79	11.70	1.75	2.29	2.94	1.93	1.14	0.63
MRNA Dec	-	-	-	-	-	-	-	-	0.00	0.07
WST Dec	0.21	0.15	0.14	0.16	0.14	0.11	0.08	0.07	0.08	0.06
VEEV Jan	-	-	-	-	-	-	-	-	-	-
CRL Dec	1.41	1.04	1.22	1.15	0.93	1.05	0.91	0.74	0.65	0.68
ALGN Dec	-	-	-	-	-	-	-	-	-	-
MTD Dec	2.06	1.79	1.75	3.07	4.72	9.81	n/m	n/m	n/m	n/m
COO Oct	0.57	0.37	0.61	0.50	0.47	0.21	0.38	0.34	0.32	0.30
ILMN Dec	0.48	0.43	0.22	0.25	0.25	0.09	0.30	0.26	0.84	0.73
Peer median	0.99	0.74	0.92	0.83	0.70	0.63	0.38	0.34	0.48	0.47

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
RVTY Dec	$2.12	$2.64	$2.13	$2.04	$6.49	$8.08	$4.50	$5.55	$2.20	$2.07
PODD Dec	−$0.48	−$0.46	$0.05	$0.19	$0.10	$0.24	$0.07	$2.94	$5.78	$3.48
MRNA Dec	−$3.79	−$4.18	−$4.95	−$1.55	−$1.96	$28.29	$20.12	−$12.33	−$9.28	−$7.26
WST Dec	$1.91	$1.99	$2.74	$3.21	$4.57	$8.67	$7.73	$7.88	$6.69	$6.79
VEEV Jan	$0.38	$0.53	$0.98	$1.47	$1.90	$2.63	-	$3.00	$3.22	$4.32
CRL Dec	$3.23	$2.54	$4.62	$5.07	$7.20	$7.60	$9.48	$9.22	$0.20	−$2.91
ALGN Dec	$2.33	$2.83	$4.92	$5.53	$22.41	$9.69	$4.61	$5.81	$5.62	$5.65
MTD Dec	$14.22	$14.24	$19.88	$22.47	$24.91	$32.78	$38.41	$35.90	$40.48	$42.05
COO Oct	$1.40	$1.88	$0.70	$2.33	$1.20	$14.79	$1.94	$1.48	$1.96	$1.87
ILMN Dec	$3.07	$4.92	$5.56	$6.74	$4.45	$5.04	−$28.00	−$7.34	−$7.69	$5.45
Peer median	$1.91	$1.99	$2.74	$3.21	$4.45	$8.67	$6.17	$3.00	$3.22	$4.32

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out RVTY and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →

Work on RVTY in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/RVTY/export.csv") into a cell.